Medication-Related Osteonecrosis of the Jaw in Patients Taking High-Dose Simvastatin

J Oral Maxillofac Surg. 2020 Jun;78(6):862-863. doi: 10.1016/j.joms.2020.01.009. Epub 2020 Jan 20.

Authors

Hadar Zigdon Giladi¹, Eran Gabay², Eli E Machtei³

Affiliations

¹ Deputy Head, Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Campus, Haifa, Israel. Electronic address: h_zigdon@rambam.health.gov.il.
² Senior Member, Department of Periodontology, School of Graduate Dentistry, Rambam Health Care Campus, Haifa, Israel.
³ Head, Department of Periodontology, and Head, School of Graduate Dentistry, Rambam Health Care Campus, Haifa, Israel.

PMID: 32061632
DOI: 10.1016/j.joms.2020.01.009

No abstract available

MeSH terms

Bisphosphonate-Associated Osteonecrosis of the Jaw*
Bone Density Conservation Agents*
Diphosphonates
Humans
Jaw
Osteonecrosis*
Simvastatin

Substances

Bone Density Conservation Agents
Diphosphonates
Simvastatin